Cardiff Oncology
CRDF
CRDF
91 hedge funds and large institutions have $41M invested in Cardiff Oncology in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 20 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
41% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 34
69% less capital invested
Capital invested by funds: $132M → $41M (-$91M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
91
Holding in Top 10
–
Calls
$348K
Puts
$468K
Top Buyers
| 1 | +$1.22M | |
| 2 | +$1.09M | |
| 3 | +$818K | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
+$805K |
| 5 |
EGM
Engineers Gate Manager
New York
|
+$609K |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$5.91M | |
| 3 | -$4.42M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.02M |
| 5 |
ACM
Altium Capital Management
New York
|
-$2.02M |